Viewing Study NCT00308295


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-26 @ 2:46 PM
Study NCT ID: NCT00308295
Status: COMPLETED
Last Update Posted: 2007-10-16
First Post: 2006-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
Sponsor: Indiana University School of Medicine
Organization:

Study Overview

Official Title: A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
Status: COMPLETED
Status Verified Date: 2007-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: